When we checked news on health care stocks and saw that Sangamo Biosciences was up following a press release announcement of a paper pointi...

When you read about it in a press release. And today's award for most egregious use of a biodollar deal total goes to Chroma Therapeutic...

Just in case you hadn’t noticed by now, swine flu is not just a public health threat, it’s also a business opportunity. Now that can be a le...

Our colleagues at the Tan Sheet think the Consumer Healthcare Products Association, the trade group representing over-the-counter drug manuf...

It’s only appropriate that on the day of the Vice Presidential debate, Alaska Newspapers Inc. is making front page news. But it’s not for...

Here are words you don’t hear too often at Washington, DC press conferences ( ed. note: or anywhere else for that matter ): “The pharmaceuti...

Whoops. It seems like that’s all that can be said about the premature announcement of FDA's still-pending approval of Amgen’s platelet d...

Merck and Schering-Plough put out a release a few minutes ago responding to critics of ENHANCE and the trial results' fallout: WHITEHOU...

Most of the releases we receive are from dedicated health care PR pros. If the topics aren't right up our alley, then they tend to be at...

Novartis posted its third quarter results this morning and missed its profit guidance . Genericization, delays to Galvus , and the withdrawa...

I suppose it’s tempting to try to spice up the news during slow summer months. But Northwest Biotherapeutics should have known better than t...

To paraphrase The Late Show With David Letterman (and Perry Como), we get press releases! Stacks and stacks of press releases! And don'...